# HUTCHMED (China) Ltd: Form 20-F for the period ended Dec 31, 2018

- Company: [HUTCHMED (China) Ltd](/companies/hcm.md) (CIK 1648257)
- Form: 20-F
- Filed: 2019-03-11
- Accepted by EDGAR: Mar 11, 2019, 07:46 ET
- Period: 2018-12-31
- Accession: 0001047469-19-001057
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1648257/000104746919001057/a2237474z20-f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1648257/000104746919001057/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2018-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2018-01-01 to 2018-12-31 | $214.1m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Research and development | 12 months, 2018-01-01 to 2018-12-31 | $114.2m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months, 2018-01-01 to 2018-12-31 | −$92.6m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2018-01-01 to 2018-12-31 | $1.0m | us-gaap:InterestExpense |
| Income tax | 12 months, 2018-01-01 to 2018-12-31 | $4.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2018-01-01 to 2018-12-31 | −$74.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2018-01-01 to 2018-12-31 | −$1.13 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2018-01-01 to 2018-12-31 | −$1.13 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2018-01-01 to 2018-12-31 | 66,426,382 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2018-01-01 to 2018-12-31 | −$32.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2018-01-01 to 2018-12-31 | $6.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 12 months, 2018-01-01 to 2018-12-31 | $5.5m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2018-12-31 | $86.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2018-12-31 | $370.5m | us-gaap:AssetsCurrent |
| Total assets | at 2018-12-31 | $532.1m | us-gaap:Assets |
| Current liabilities | at 2018-12-31 | $85.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2018-12-31 | $119.9m | us-gaap:Liabilities |
| Long-term debt | at 2018-12-31 | $26.7m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | at 2018-12-31 | $389.0m | us-gaap:StockholdersEquity |
| Shares outstanding | at 2018-12-31 | 66,657,745 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1648257/000104746919001057/a2237474z20-f.htm

Filed Mar 11, 2019.
Source: SEC EDGAR, the filing index for accession 0001047469-19-001057. Last ingested by Listed: Oct 29, 2026, 06:09 ET. No prices; not investment advice.